Prosecution Insights
Last updated: November 20, 2026

Dilek B Cobanoglu, USPTO Patent Examiner

Listed by the USPTO as COBANOGLU, DILEK B

Tech Center 3600 • Art Units: 3626 3627 3683 3686 3687

This examiner grants 33% of resolved cases

Analysis

COBANOGLU, DILEK B is assigned to tech center 3600 and art unit 3626. The profile records 509 resolved cases, with an allowance rate of 33.2%. The median time to allowance is 1602 days, so applicants should account for a lengthy prosecution interval when developing portfolio timing expectations.

The interview lift is 27.4%, indicating a positive association between interviews and allowance outcomes despite the lower allowance rate in the overall record. The listed companies are Cerner Innovation Inc., Biotronik SE & Co. KG, and KPN Innovations LLC. The recurring firms are Invoke, BUCHANAN INGERSOLL & ROONEY PC, and CALDWELL LLC. The substantial case volume makes the profile useful for historical benchmarking, but application-specific rejection analysis remains necessary before drawing a prosecution recommendation.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

33.2%
Allow Rate
-18.8% vs TC avg
560
Total Applications
+27.4%
Interview Lift
1602
Avg Prosecution Days
Based on 509 resolved cases, 2023–2026

Rejection Statute Breakdown

36.8%
§101 Eligibility
20.4%
§102 Novelty
26.9%
§103 Obviousness
14.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19040945 ENVIRONMENTAL INFORMATION COLLECTION DEVICE, ENVIRONMENTAL INFORMATION COLLECTION METHOD, AND RECORDING MEDIUM Final Rejection NEC Corporation
17613774 METHODS AND APPARATUS FOR GENERATING A GRAPHICAL REPRESENTATION Final Rejection KONINKLIJKE PHILIPS N.V.
18698097 AUTOMATIC RADIOTHERAPY PRESCRIPTION ANOMALY DETECTION Non-Final OA THE JOHNS HOPKINS UNIVERSITY
19474449 Peripheral artery disease step counter Non-Final OA BIOTRONIK SE & Co. KG
18553643 Medical Support System and Medical Support Method for Patient Treatment Final Rejection BIOTRONIK SE & Co. KG
18714365 METHOD FOR CLASSIFYING A MEDICAL DEVICE AND/OR DRUG, SYSTEM AND TRAINING METHOD Non-Final OA BIOTRONIK AG
17931293 SYSTEMS AND METHODS FOR END-TO-END PET CARE TRANSACTIONS WEB PLATFORM Non-Final OA Mars, Incorporated
18938009 SYSTEM AND METHOD FOR MODIFYING A NUTRITION REQUIREMENT Final Rejection KPN INNOVATIONS LLC
18521997 APPARATUS AND METHOD FOR OUTPUTTING AN ALIMENTARY PROGRAM TO A USER Non-Final OA KPN INNOVATIONS, LLC.
18439997 MEDICAL DEVICE FOR ESTIMATING RISK OF PATIENT DETERIORATION Non-Final OA ZOLL Medical Corporation
19222755 MEDICANT DELIVERY SYSTEM, METHODS OF PROVIDING RECOMMENDATIONS REGARDING MEDICANT DELIVERY, AND RELATED SYSTEMS AND METHODS Final Rejection Insulet Corporation
17150372 INTELLIGENT SITUATIONAL ALARMS AND NOTIFICATIONS FOR DIABETES MANAGEMENT DEVICES Non-Final OA Insulet Corporation
19026246 Integrated Coordination Of Care Final Rejection Cerner Innovation, Inc.
19026234 Integrated Coordination Of Care Final Rejection Cerner Innovation, Inc.
18767726 Integrated Coordination Of Care Non-Final OA Cerner Innovation, Inc.
18828556 SYSTEMS AND METHODS FOR USING AI ML TO PREDICT, BASED ON DATA ANALYTICS OR BIG DATA, AN OPTIMAL NUMBER OR RANGE OF REHABILITATION SESSIONS FOR A USER Final Rejection ROM TECHNOLOGIES, INC.
18235510 METHOD FOR PREDICTING RISK OF DEPRESSION RELAPSE OR ONSET Non-Final OA IQVIA Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Dilek B Cobanoglu's allowance rate?

33.2% of resolved applications examined by Dilek B Cobanoglu were allowed (509 resolved cases), compared with 24.9% across Art Unit 3626 over the last five years.

Does an interview help with examiner Dilek B Cobanoglu?

This examiner's interview lift is +27.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Dilek B Cobanoglu take to allow a patent?

Applications allowed by Dilek B Cobanoglu took 1,602 days on average from filing to allowance.

Which art unit does examiner Dilek B Cobanoglu work in?

Dilek B Cobanoglu examines applications in Art Unit 3626 in Tech Center 3600 (Transportation, E-Commerce & Mechanical Systems).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month